{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:59:15Z","timestamp":1771066755245,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00415-019-09262-8","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T16:49:04Z","timestamp":1551718144000},"page":"1332-1339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Dorsal root ganglia volume is increased in patients with the Fabry-related GLA variant p.D313Y"],"prefix":"10.1007","volume":"266","author":[{"given":"Tim","family":"Godel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"B\u00e4umer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Stumpfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Muschol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Kronlage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merle","family":"Brunn\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Kollmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Heiland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bendszus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor-Felix","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"issue":"6","key":"9262_CR1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/humu.10275","volume":"22","author":"M Yasuda","year":"2003","unstructured":"Yasuda M, Shabbeer J, Benson SD, Maire I, Burnett RM, Desnick RJ (2003) Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele. Hum Mutat 22(6):486\u2013492. \n                    https:\/\/doi.org\/10.1002\/humu.10275","journal-title":"Hum Mutat"},{"issue":"6","key":"9262_CR2","first-page":"1186","volume":"53","author":"CM Eng","year":"1993","unstructured":"Eng CM, Resnick-Silverman LA, Niehaus DJ, Astrin KH, Desnick RJ (1993) Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease. Am J Hum Genet 53(6):1186\u20131197","journal-title":"Am J Hum Genet"},{"issue":"8","key":"9262_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/00365513.2017.1390782","volume":"77","author":"L Hasholt","year":"2017","unstructured":"Hasholt L, Ballegaard M, Bundgaard H, Christiansen M, Law I, Lund AM, Norremolle A, Krogh Rasmussen A, Ravn K, Tumer Z, Wibrand F, Feldt-Rasmussen U (2017) The D313Y variant in the GLA gene - no evidence of a pathogenic role in Fabry disease. Scand J Clin Lab Invest 77(8):617\u2013621. \n                    https:\/\/doi.org\/10.1080\/00365513.2017.1390782","journal-title":"Scand J Clin Lab Invest"},{"issue":"4","key":"9262_CR4","doi-asserted-by":"publisher","first-page":"e010422","DOI":"10.1136\/bmjopen-2015-010422","volume":"6","author":"D Oder","year":"2016","unstructured":"Oder D, Uceyler N, Liu D, Hu K, Petritsch B, Sommer C, Ertl G, Wanner C, Nordbeck P (2016) Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y. BMJ Open 6(4):e010422. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2015-010422","journal-title":"BMJ Open"},{"key":"9262_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/8904_2012_154","volume":"7","author":"M Niemann","year":"2013","unstructured":"Niemann M, Rolfs A, Giese A, Mascher H, Breunig F, Ertl G, Wanner C, Weidemann F (2013) Lyso-Gb3 indicates that the alpha-galactosidase a mutation D313Y is not clinically relevant for fabry disease. JIMD Rep 7:99\u2013102. \n                    https:\/\/doi.org\/10.1007\/8904_2012_154","journal-title":"JIMD Rep"},{"issue":"9","key":"9262_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","volume":"8","author":"CM Eng","year":"2006","unstructured":"Eng CM, Germain DP, Banikazemi M, Warnock DG, Wanner C, Hopkin RJ, Bultas J, Lee P, Sims K, Brodie SE, Pastores GM, Strotmann JM, Wilcox WR (2006) Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med 8(9):539\u2013548. \n                    https:\/\/doi.org\/10.1097\/01.gim.0000237866.70357.c6","journal-title":"Genet Med"},{"issue":"5","key":"9262_CR7","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/cge.13007","volume":"92","author":"M Moulin du","year":"2017","unstructured":"du Moulin M, Koehn AF, Golsari A, Dulz S, Atiskova Y, Patten M, Munch J, Avanesov M, Ullrich K, Muschol N (2017) The mutation p.D313Y is associated with organ manifestation in Fabry disease. Clin Genet 92(5):528\u2013533. \n                    https:\/\/doi.org\/10.1111\/cge.13007","journal-title":"Clin Genet"},{"issue":"10","key":"9262_CR8","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1093\/ndt\/gfr084","volume":"26","author":"M Selvarajah","year":"2011","unstructured":"Selvarajah M, Nicholls K, Hewitson TD, Becker GJ (2011) Targeted urine microscopy in Anderson-Fabry disease: a cheap, sensitive and specific diagnostic technique. Nephrol Dial Transpl 26(10):3195\u20133202. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfr084","journal-title":"Nephrol Dial Transpl"},{"issue":"12","key":"9262_CR9","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/WNL.0000000000004396","volume":"89","author":"T Godel","year":"2017","unstructured":"Godel T, Baumer P, Pham M, Kohn A, Muschol N, Kronlage M, Kollmer J, Heiland S, Bendszus M, Mautner VF (2017) Human dorsal root ganglion in vivo morphometry and perfusion in Fabry painful neuropathy. Neurology 89(12):1274\u20131282. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004396","journal-title":"Neurology"},{"issue":"4","key":"9262_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/jmg.20.4.309","volume":"20","author":"N Gadoth","year":"1983","unstructured":"Gadoth N, Sandbank U (1983) Involvement of dorsal root ganglia in Fabry\u2019s disease. J Med Genet 20(4):309\u2013312","journal-title":"J Med Genet"},{"key":"9262_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-9053-y","author":"T Godel","year":"2018","unstructured":"Godel T, Kohn A, Muschol N, Kronlage M, Schwarz D, Kollmer J, Heiland S, Bendszus M, Mautner VF, Baumer P (2018) Dorsal root ganglia in vivo morphometry and perfusion in female patients with Fabry disease. J Neurol. \n                    https:\/\/doi.org\/10.1007\/s00415-018-9053-y","journal-title":"J Neurol"},{"issue":"4","key":"9262_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","volume":"65","author":"C Whybra","year":"2004","unstructured":"Whybra C, Kampmann C, Krummenauer F, Ries M, Mengel E, Miebach E, Baehner F, Kim K, Bajbouj M, Schwarting A, Gal A, Beck M (2004) The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 65(4):299\u2013307. \n                    https:\/\/doi.org\/10.1111\/j.1399-0004.2004.00219.x","journal-title":"Clin Genet"},{"key":"9262_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neuroimage.2016.07.030","volume":"141","author":"T Godel","year":"2016","unstructured":"Godel T, Pham M, Heiland S, Bendszus M, Baumer P (2016) Human dorsal-root-ganglion perfusion measured in-vivo by MRI. Neuroimage 141:81\u201387. \n                    https:\/\/doi.org\/10.1016\/j.neuroimage.2016.07.030","journal-title":"Neuroimage"},{"key":"9262_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1744-8069-4-10","volume":"4","author":"JM Jimenez-Andrade","year":"2008","unstructured":"Jimenez-Andrade JM, Herrera MB, Ghilardi JR, Vardanyan M, Melemedjian OK, Mantyh PW (2008) Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: implications for chemical-induced peripheral sensory neuropathies. Mol Pain 4:10. \n                    https:\/\/doi.org\/10.1186\/1744-8069-4-10","journal-title":"Mol Pain"},{"issue":"3","key":"9262_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/00001756-200403010-00004","volume":"15","author":"H Hirakawa","year":"2004","unstructured":"Hirakawa H, Okajima S, Nagaoka T, Kubo T, Takamatsu T, Oyamada M (2004) Regional differences in blood-nerve barrier function and tight-junction protein expression within the rat dorsal root ganglion. Neuroreport 15(3):405\u2013408","journal-title":"Neuroreport"},{"issue":"8","key":"9262_CR16","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1073\/pnas.0712309105","volume":"105","author":"JM Aerts","year":"2008","unstructured":"Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, van Roomen C, Mirzaian M, Wijburg FA, Linthorst GE, Vedder AC, Rombach SM, Cox-Brinkman J, Somerharju P, Boot RG, Hollak CE, Brady RO, Poorthuis BJ (2008) Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci USA 105(8):2812\u20132817. \n                    https:\/\/doi.org\/10.1073\/pnas.0712309105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"9262_CR17","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.bbadis.2010.05.003","volume":"1802","author":"SM Rombach","year":"2010","unstructured":"Rombach SM, Dekker N, Bouwman MG, Linthorst GE, Zwinderman AH, Wijburg FA, Kuiper S, Vd Bergh Weerman MA, Groener JE, Poorthuis BJ, Hollak CE, Aerts JM (2010) Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease. Biochim Biophys Acta 1802(9):741\u2013748. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2010.05.003","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"9262_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/CIRCGENETICS.113.000249","volume":"7","author":"M Niemann","year":"2014","unstructured":"Niemann M, Rolfs A, Stork S, Bijnens B, Breunig F, Beer M, Ertl G, Wanner C, Weidemann F (2014) Gene mutations versus clinically relevant phenotypes: lyso-Gb3 defines Fabry disease. Circ Cardiovasc Genet 7(1):8\u201316. \n                    https:\/\/doi.org\/10.1161\/CIRCGENETICS.113.000249","journal-title":"Circ Cardiovasc Genet"},{"key":"9262_CR19","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1038\/ki.2008.522","volume":"111","author":"R Torra","year":"2008","unstructured":"Torra R (2008) Renal manifestations in Fabry disease and therapeutic options. Kidney Int Suppl 111:S29\u2013S32. \n                    https:\/\/doi.org\/10.1038\/ki.2008.522","journal-title":"Kidney Int Suppl"},{"issue":"11","key":"9262_CR20","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1136\/jnnp.2008.143693","volume":"79","author":"S Buechner","year":"2008","unstructured":"Buechner S, Moretti M, Burlina AP, Cei G, Manara R, Ricci R, Mignani R, Parini R, Di Vito R, Giordano GP, Simonelli P, Siciliano G, Borsini W (2008) Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study. J Neurol Neurosurg Psychiatry 79(11):1249\u20131254. \n                    https:\/\/doi.org\/10.1136\/jnnp.2008.143693","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"9262_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/STROKEAHA.109.570499","volume":"41","author":"MV Baptista","year":"2010","unstructured":"Baptista MV, Ferreira S, Pinho EMT, Carvalho M, Cruz VT, Carmona C, Silva FA, Tuna A, Rodrigues M, Ferreira C, Pinto AA, Leitao A, Gabriel JP, Calado S, Oliveira JP, Ferro JM, Investigators POYS (2010) Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study-screening genetic conditions in Portuguese young stroke patients. Stroke 41(3):431\u2013436. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.109.570499","journal-title":"Stroke"},{"issue":"1","key":"9262_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/STROKEAHA.114.006283","volume":"46","author":"E Kolodny","year":"2015","unstructured":"Kolodny E, Fellgiebel A, Hilz MJ, Sims K, Caruso P, Phan TG, Politei J, Manara R, Burlina A (2015) Cerebrovascular involvement in Fabry disease: current status of knowledge. Stroke 46(1):302\u2013313. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.114.006283","journal-title":"Stroke"},{"issue":"3","key":"9262_CR23","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","volume":"40","author":"K Sims","year":"2009","unstructured":"Sims K, Politei J, Banikazemi M, Lee P (2009) Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke 40(3):788\u2013794. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.108.526293","journal-title":"Stroke"},{"issue":"1","key":"9262_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/ASN.2012030316","volume":"24","author":"C Tondel","year":"2013","unstructured":"Tondel C, Bostad L, Larsen KK, Hirth A, Vikse BE, Houge G, Svarstad E (2013) Agalsidase benefits renal histology in young patients with Fabry disease. J Am Soc Nephrol 24(1):137\u2013148. \n                    https:\/\/doi.org\/10.1681\/ASN.2012030316","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"9262_CR25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/jmedgenet-2016-104178","volume":"54","author":"DA Hughes","year":"2017","unstructured":"Hughes DA, Nicholls K, Shankar SP, Sunder-Plassmann G, Koeller D, Nedd K, Vockley G, Hamazaki T, Lachmann R, Ohashi T, Olivotto I, Sakai N, Deegan P, Dimmock D, Eyskens F, Germain DP, Goker-Alpan O, Hachulla E, Jovanovic A, Lourenco CM, Narita I, Thomas M, Wilcox WR, Bichet DG, Schiffmann R, Ludington E, Viereck C, Kirk J, Yu J, Johnson F, Boudes P, Benjamin ER, Lockhart DJ, Barlow C, Skuban N, Castelli JP, Barth J, Feldt-Rasmussen U (2017) Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study. J Med Genet 54(4):288\u2013296. \n                    https:\/\/doi.org\/10.1136\/jmedgenet-2016-104178","journal-title":"J Med Genet"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09262-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09262-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09262-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:13:37Z","timestamp":1583194417000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09262-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["9262"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09262-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]},"assertion":[{"value":"13 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}